Kijima T, Fukushima H, and Kusuhara S, et al (2020) Association between the occurrence and spectrum of immune-related adverse events and efficacy of pembrolizumab in asian patients with advanced urothelial cancer: multicenter retrospective analyses and systematic literature review Clin Genitourin Cancer 19 208216 PMID: 32800718 63
If your current protocol uses IM, switching to SubQ isn't an upgrade
Nonetheless, the long-term administration of GLP-1 RAs requires vigilant monitoring to minimize potential adverse effects, including gastrointestinal disturbances and pancreatic overstimulation
In this context, we note that the remarkable effects of GLP-1RAs in achieving weight loss may fail to be maintained over the long term once medications are stopped 247
The FDA warns they pose serious safety risks, including allergic reactions
For those exploring alternatives entirely, the Ozempic alternatives article surveys the full landscape, and the retatrutide dosage chart covers the triple-agonist approach